Acurx Pharmaceuticals Statistics
Total Valuation
ACXP has a market cap or net worth of $29.37 million. The enterprise value is $21.90 million.
| Market Cap | 29.37M |
| Enterprise Value | 21.90M |
Important Dates
The next confirmed earnings date is Wednesday, May 15, 2024, before market open.
| Earnings Date | May 15, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ACXP has 14.47 million shares outstanding. The number of shares has increased by 17.15% in one year.
| Shares Outstanding | 14.47M |
| Shares Change (YoY) | +17.15% |
| Shares Change (QoQ) | +6.42% |
| Owned by Insiders (%) | 15.26% |
| Owned by Institutions (%) | 11.74% |
| Float | 13.35M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 6.29 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.53, with zero debt.
| Current Ratio | 2.53 |
| Quick Ratio | 2.50 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -289.70% and return on invested capital (ROIC) is -312.38%.
| Return on Equity (ROE) | -289.70% |
| Return on Assets (ROA) | -185.20% |
| Return on Capital (ROIC) | -312.38% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.64M |
| Employee Count | 4 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -37.15% in the last 52 weeks. The beta is -1.90, so ACXP's price volatility has been lower than the market average.
| Beta (1Y) | -1.90 |
| 52-Week Price Change | -37.15% |
| 50-Day Moving Average | 2.46 |
| 200-Day Moving Average | 2.90 |
| Relative Strength Index (RSI) | 46.41 |
| Average Volume (30 Days) | 102,332 |
Short Selling Information
The latest short interest is 337,407, so 2.33% of the outstanding shares have been sold short.
| Short Interest | 337,407 |
| Short Previous Month | 294,472 |
| Short % of Shares Out | 2.33% |
| Short % of Float | 2.53% |
| Short Ratio (days to cover) | 3.96 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -14.58M |
| Pretax Income | -14.58M |
| Net Income | -14.58M |
| EBITDA | -14.58M |
| EBIT | -14.58M |
| Earnings Per Share (EPS) | -$1.15 |
Balance Sheet
The company has $7.47 million in cash and no debt, giving a net cash position of $7.47 million or $0.52 per share.
| Cash & Cash Equivalents | 7.47M |
| Total Debt | n/a |
| Net Cash | 7.47M |
| Net Cash Per Share | $0.52 |
| Equity / Book Value | 4.67M |
| Book Value Per Share | 0.32 |
| Working Capital | 4.67M |
Cash Flow
| Operating Cash Flow | -9.80M |
| Capital Expenditures | n/a |
| Free Cash Flow | -9.80M |
| FCF Per Share | -$0.77 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ACXP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -17.15% |
| Shareholder Yield | -17.15% |
| Earnings Yield | -49.63% |
| FCF Yield | -33.37% |
Analyst Forecast
The average price target for ACXP is $12.00, which is 491.13% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $12.00 |
| Price Target Difference | 491.13% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |